insuline PEN

DIABNEXT® unveils 4 innovative smarts Pens models in 2015

Attending the 51st EASD Annual Meeting, Stockholm, Sweden, 14-18 September 2015, DIABNEXT® announces today its pipeline of R&D innovations in auto injection systems will unveil 4 models of smart auto injection pens by the end of 2015.

Richard Binier CEO declared “After very successful innovation awards at CES 2015, we have tripled DIABNEXT®’s R&D teams and investments in auto-injections systems for Diabetes and other rare or chronic diseases. While 2015 remains a year of technical developments and IP patenting, our company is gearing up for market launches in several countries as early as 2016”.